Lexicon Pharmaceuticals, Inc.
XNAS:LXRX
1.7
$1.84 - 10.00
$1.30 - 10.00
$1.65
$1.79
$1.78
$1.76
1.83
0.28
3460536
3432733.6
184052145.13
Chart
TendieTensor AI Analysis
Company
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Fundamentals
103
-8.970000
5.141390
100
BBG000BQ85G2
BBG001SDWCZ8
363.40M
363.40M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own LXRX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.